drug · small molecule
curcumin
Phase 1updated 3mo agoby Vascarta Inc🔗 ChEMBL
Phase 1community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 46 investigational indications.
indications
indications
Sickle Cell Disease
all catalysts(0)
nothing on the calendar yet
Trials studying curcumin
- N/ACurcumin in Kidney Transplant Recipients
- N/ASingle Oral Dose Comparative Bioavailability Study of Investigational Product in Healthy Human Subjects Under Fasting Conditions.
- N/ACurcumin Supplementation in Cervical Cancer
- phase3The Effect of Supplementation with Curcuminoids for the Improvement of Musculoskeletal Conditions in Sedentary Adults
- N/ABioavailability Evaluation of CurQ+ Curcumin Formulation
- phase4Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users
- N/AEfficacy and Safety of Curcumin Formulation in Alzheimer's Disease
- N/AEffects of Curcumin-containing Toothpaste on Dental Biofilm and Associated Oral Halitosis
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that